Martin R Edelmann

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 13

Top Topics

Cerebrospinal Fluid

Top Venues

Pharmaceuticals (Basel, Switzerland)

Journal of labelled compounds & radiopharmaceuticals

Bioconjugate chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Martin R Edelmann, Johannes Erny, Wolfgang Guba, Markus Hierl
Tritium Labeling of Neuromedin S by Conjugation with [ 3 H] N -Succinimidyl Propionate. ACS omega 8 (2) (2023)
Martin R Edelmann, Christoph Bredack, Sara Belli, Peter Mohr, Marie-Paule Imhoff, Flore Reggiani, Eric A Kusznir, Arne C Rufer, Daniel P Holt, Heather Valentine, Dean F Wong, Robert F Dannals, Michael Honer, Luca C Gobbi
Evaluation of Tetrazine Tracers for Pretargeted Imaging within the Central Nervous System. Bioconjugate chemistry (2023)
Martin R Edelmann, Johannes Erny, Wolfgang Guba, Markus Hierl
Tritium Labeling of Neuromedin S by Conjugation with [ 3 H] N -Succinimidyl Propionate. ACS omega 8 (2) (2023)
Martin R Edelmann
Radiolabelling small and biomolecules for tracking and monitoring. RSC advances 12 (50) (2022)
Christoph Bredack, Martin R Edelmann, Edilio Borroni, Luca C Gobbi, Michael Honer
Antibody-Based In Vivo Imaging of Central Nervous System Targets-Evaluation of a Pretargeting Approach Utilizing a TCO-Conjugated Brain Shuttle Antibody and Radiolabeled Tetrazines. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Christoph Bredack, Martin R Edelmann, Edilio Borroni, Luca C Gobbi, Michael Honer
Antibody-Based In Vivo Imaging of Central Nervous System Targets-Evaluation of a Pretargeting Approach Utilizing a TCO-Conjugated Brain Shuttle Antibody and Radiolabeled Tetrazines. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Christoph Bredack, Martin R Edelmann, Edilio Borroni, Luca C Gobbi, Michael Honer
Antibody-Based In Vivo Imaging of Central Nervous System Targets-Evaluation of a Pretargeting Approach Utilizing a TCO-Conjugated Brain Shuttle Antibody and Radiolabeled Tetrazines. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Christoph Bredack, Martin R Edelmann, Edilio Borroni, Luca C Gobbi, Michael Honer
Antibody-Based In Vivo Imaging of Central Nervous System Targets-Evaluation of a Pretargeting Approach Utilizing a TCO-Conjugated Brain Shuttle Antibody and Radiolabeled Tetrazines. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Martin R Edelmann, Thorsten Muser
Tritium O-Methylation of N-Alkoxy Maleimide Derivatives as Labeling Reagents for Biomolecules. Bioconjugate chemistry 32 (5) (2021)
Martin R Edelmann, Simon Hauri
Functional in vitro assessment of modified antibodies: Impact of label on protein properties. PloS one 16 (9) (2021)
Simone Schadt, Simon Hauri, Filipe Lopes, Martin R Edelmann, Roland F Staack, Roberto Villaseñor, Hubert Kettenberger, Adrian B Roth, Franz Schuler, Wolfgang F Richter, Christoph Funk
Are Biotransformation Studies of Therapeutic Proteins Needed? Scientific Considerations and Technical Challenges. Drug metabolism and disposition: the biological fate of chemicals 47 (12) (2020)
Martin R Edelmann, Hubert Kettenberger, Alexander Knaupp, Tilman Schlothauer, Michael B Otteneder
Radiolabeled IgG antibodies: Impact of various labels on neonatal Fc receptor binding. Journal of labelled compounds & radiopharmaceuticals 62 (11) (2019)
Dieter Muri, Martin R Edelmann
Tools for work-up and prepurification of tritium-labeled small molecules. Journal of labelled compounds & radiopharmaceuticals 61 (12) (2018)